3 clinical-grade skincare creams you really shouldn’t buy online 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility? 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
Volunteers in the upcoming COVID-19 vaccine trial research have agreed to be infected with the virus. They volunteered to help find something that will help people become immune to the highly contagious disease that is currently gripping the world today.
The controversial trial method to find the coronavirus vaccine
This trial research has been dubbed as the “human challenge” since it involves a deliberate infection of healthy people to find an effective vaccine and possible COVID-19 cure. But then, while many have taken the challenge by volunteering themselves for the trial, some people are questioning its value.
This method of testing possible vaccines has now become controversial because it may not be ethical and safe. Researchers in the U.K. are the first to try this technique of studying the disease and develop potential vaccines by infecting volunteers, as per the Imperial College London.
“Human challenge studies can increase our understanding of COVID-19 in unique ways and accelerate the development of the many potential new COVID-19 treatments and vaccines,” lead researcher from the Department of Infectious Disease at Imperial College London, Dr, Chris Chiu, said. “Our number one priority is the safety of the volunteers. My team has been safely running human challenge studies with other respiratory viruses for over 10 years.”
Ensuring the safety of the volunteers and government support
He added that all researches are not risk-free so this “human challenge” for the COVID-19 vaccine is common. He assured though that they will be working with partners in the program to make sure that the risk will be very low.
“The UK’s experience and expertise in human challenge trials as well as in wider COVID-19 science will help us tackle the pandemic,” he added. “This will be beneficial for people in the UK and worldwide."
At any rate, this trial will be strictly reviewed by the ethics committee before volunteers are officially enrolled in the research. They will also seek approval from the Medicines and Healthcare products Regulatory Agency (MHRA) before proceeding with the “human challenge” study trial for vaccines.
Finally, as per ABC7 News, the U.K. government is planning to invest £33.6 million or $43.4 million in this research.
